Am J Gastroenterol
- KADOTA T, Abe S, Uedo N, Doyama H, et al
Comparison of effective imaging modalities for detecting gastric neoplasms: A
randomized three-arm phase II trial.
Am J Gastroenterol. 2024 May 16. doi: 10.14309/ajg.0000000000002871.
- SHAHEEN NJ, Odze RD, Singer ME, Salyers WJ, et al
Adjunctive Use of Wide-Area Transepithelial Sampling-3D in Patients With
Symptomatic Gastroesophageal Reflux Increases Detection of Barrett's Esophagus
and Dysplasia.
Am J Gastroenterol. 2024;119:1990-2001.
Ann Otol Rhinol Laryngol
- GARRETT S, Millay D, Pierre J, Pluta N, et al
Monitoring Outcomes of Indeterminate Thyroid Nodules and Predictive Capabilities
of Molecular Testing.
Ann Otol Rhinol Laryngol. 2024;133:873-878.
BMC Cancer
- ZHANG Y, Meng Z, Lu M, Ruan S, et al
Study of the significance of the combination of the fibrinogen-albumin ratio and
sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing
radical surgery.
BMC Cancer. 2024;24:1265.
- GHORBANPOUR M, Salarvand S, Salarvand S, Shahsavari F, et al
Depth of invasion and extranodal extension: the influential factors to predict
survival rate of patients with oral tongue squamous cell carcinoma.
BMC Cancer. 2024;24:1256.
- XIONG W, Xie Y, Wang D, Huang X, et al
Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal
cancer cells through suppressing MAPK and AKT signaling.
BMC Cancer. 2024;24:1236.
BMC Surg
- CHEN Y, Ma Y, Wu H, Wei X, et al
Examining the relationship between preoperative nutritional and symptom
assessment and postoperative atrial fibrillation in esophageal squamous cell
carcinoma patients: a retrospective cohort study.
BMC Surg. 2024;24:298.
Br J Cancer
- CHEN YY, Wang PP, Hu Y, Yuan Y, et al
Clinical efficacy and immune response of neoadjuvant camrelizumab plus
chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma:
a phase 2 trial.
Br J Cancer. 2024;131:1126-1136.
Dis Esophagus
- ST-PIERRE J, Coca-Martinez M, Drummond K, Minnella E, et al
Multimodal prehabilitation to enhance functional capacity of patients with
esophageal cancer during concurrent neoadjuvant chemotherapies-a randomized
feasibility trial.
Dis Esophagus. 2024 Oct 8:doae087. doi: 10.1093.
- SAWAI S, Nakatani E, Sato S, Hawke P, et al
Peak expiratory flow predicts the occurrence of postoperative pneumonia after
esophagectomy for esophageal cancer.
Dis Esophagus. 2024 Oct 10:doae084. doi: 10.1093.
J Laryngol Otol
- FISHMAN J, Fisher E
Otogenic brain complications, simulation training and low-molecular-weight
heparin salvage in pedicled flap head and neck reconstruction.
J Laryngol Otol. 2024;138:827.
- PANDA S, Gautam V, Mitra S, Singh CA, et al
Low-molecular-weight heparin salvage in pedicled flap reconstruction in head and
neck: a prospective cohort study.
J Laryngol Otol. 2024;138:852-857.
Laryngoscope
- TANG A, Li J, Scheff N, Johnson JT, et al
Quality of Life Outcomes for Parotid Malignancies.
Laryngoscope. 2024;134:4549-4556.
- HARRISON DB, Phillips AL, Tansey JB, Clarke TJ, et al
Brown Adipose Tissue Mimicking Head and Neck Cancer on PET Scan in a Patient on
GLP-1 Drug.
Laryngoscope. 2024 Oct 7. doi: 10.1002/lary.31815.
- HINTZE JM, Cleere E, Griffin J, O'Riordan I, et al
Primary Site Influences the Ability of Magnetic Resonance Imaging to Assess
Cartilage Invasion in Advanced Laryngeal Cancer.
Laryngoscope. 2024 Oct 5. doi: 10.1002/lary.31822.
Oral Oncol
- AWEEDA M, Richard K, Arnaud EH, Divi V, et al
Factors influencing lymph node yield in head and neck squamous cell carcinoma: A
scoping review.
Oral Oncol. 2024;159:107070.
- HE SQ, Liu GY, Yu YH, Wang L, et al
Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients
receiving immuno-chemotherapy: A multicenter, retrospective cohort study.
Oral Oncol. 2024;159:107074.
- LEE RH, Evans C, Alqasieer Y, Knott PD, et al
Bite me: Can active biting during trismus therapy improve mouth opening in head
and neck cancer patients?
Oral Oncol. 2024;159:107064.
- ZHAO BY, Hirayama S, Goss D, Zhao Y, et al
Human papillomavirus-associated nasopharyngeal carcinoma: A systematic review and
meta-analysis.
Oral Oncol. 2024;159:107057.
Otolaryngol Head Neck Surg
- WANG J, Li F, Feng Y, Kong D, et al
An Improved Staging System of Adenoid Cystic Carcinoma in the External Auditory
Canal.
Otolaryngol Head Neck Surg. 2024 May 15. doi: 10.1002.
- WASHINGTON CJ, Abouyared M, Karanth S, Braithwaite D, et al
The Use of Chatbots in Head and Neck Mucosal Malignancy Treatment
Recommendations.
Otolaryngol Head Neck Surg. 2024;171:1062-1068.
- IYOHA EM, Jenkins SM, Guo R, Choby G, et al
Outcomes of Immunotherapy in Sinonasal Mucosal Melanoma Patients With Recurrent
and Metastatic Disease.
Otolaryngol Head Neck Surg. 2024;171:1245-1249.
- MOCHARNUK J, Daniels KE, Filimonov A, North LM, et al
The Prognostic Implications of Neutrophil-to-Lymphocyte Ratio in Olfactory
Neuroblastoma.
Otolaryngol Head Neck Surg. 2024;171:1212-1216.
PLoS One
- ALFURAIH AM, Alotaibi AM, Alshammari AK, Alrashied BF, et al
Evaluating diagnostic accuracy and agreement of TI-RADS scoring in thyroid
nodules: A comparative analysis between sonographers and radiologists.
PLoS One. 2024;19:e0312121.
Radiother Oncol
- LIANG Z, Luo C, Li S, Zhu Y, et al
Guiding induction chemotherapy of locoregionally advanced nasopharyngeal
carcinoma with ternary classification of predicted individual treatment effect.
Radiother Oncol. 2024 Oct 9:110571. doi: 10.1016/j.radonc.2024.110571.
Surgery
- MACHENS A, Dralle H
Response to letter to the editor on "Sporadic noninvasive medullary thyroid
neoplasm: A desmoplasia-negative, unifocal, nonmetastatic tumor cured by
hemithyroidectomy".
Surgery. 2024 Aug 30:S0039-6060(24)00222-8. doi: 10.1016/j.surg.2024.
- KIM LT
Invited commentary on: YMSY-D-23-01181_R2. Overexpression of human DNA polymerase
theta (POLQ) is a biomarker of aggressive and DNA repair-deficient papillary
thyroid cancers.
Surgery. 2024 Aug 20:S0039-6060(24)00543-9. doi: 10.1016/j.surg.2024.
- FRYE CC, Tennant L, Yeager A, Azimzadeh P, et al
Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA
repair-deficient papillary thyroid cancers.
Surgery. 2024 Jun 18:S0039-6060(24)00303-9. doi: 10.1016/j.surg.2024.
Thyroid
- KROPINSKA A, Ledwon A, Paliczka Cieslik E, Olczyk T, et al
Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in
Poland: A Retrospective Cohort Study Spanning 45 Years.
Thyroid. 2024 Sep 25. doi: 10.1089/thy.2024.0109.
- MASTNIKOVA K, Bulanova Pekova B, Kuklikova V, Vaclavikova E, et al
DICER1 Variants in Pediatric and Young Adult Thyroid Nodules.
Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0188.
- LEE JY, Lee MK, Lee JH, Kim K, et al
Cancer risks of patients with Graves' disease who received antithyroid drugs as
initial treatment: A nationwide population-based analysis.
Thyroid. 2024 Sep 3. doi: 10.1089/thy.2024.0178.
- WANG Z, Yao Q, Bao L, Chang H, et al
Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid
Cancer: A Single-center Retrospective Cohort Study in a Chinese Population.
Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0151.
- PRINZI A, van Velsen EFS, Belfiore A, Frasca F, et al
Brain Metastasis in Differentiated Thyroid Cancer: Clinical Presentation,
Diagnosis and Management.
Thyroid. 2024 Aug 20. doi: 10.1089/thy.2024.0240.
- WEN S, Wu Y, Wang JY, Ni Z, et al
BRAFV600E/ p-ERK/ p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of
Glucose Metabolism in Papillary Thyroid Cancer.
Thyroid. 2024 Aug 20. doi: 10.1089/thy.2023.0700.
- RICARTE-FILHO JC, Reichenberger ER, Hinkle K, Isaza A, et al
TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid
Cancer.
Thyroid. 2024 Aug 6. doi: 10.1089/thy.2024.0224.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016